W. Boersma (Alkmaar, The Netherlands), G. Dimopoulos (Athens, Greece)
Impact of bronchial airflow limitation and recent respiratory tract infection on the circulating level of C-reactive protein in an elderly population H. Melbye, D. S. Halvorsen, A. Medbo, J. Brox, I. Njolstad (Tromso, Norway)
| |
Procalcitonin and C reactive protein as markers of treatment failure in community-acquired pneumonia R. Menéndez, M. Cavalcanti, S. Reyes, I. Aldabó, J. Mensa, R. Martinez, X. Filella, A. Torres (Valencia, Barcelona, Spain)
| |
C-reactive protein in community-acquired pneumonia B. Miranda, M. G. Clemente, L. Molinos, C. Álvarez, B. del Busto, B. R. Cocina, F. Álvarez, J. Gorostidi, C. Orejas, Nacastur Group Asturpar (Oviedo, Avilés, Gijón, Cangas del Narcea, Jarrio - Coaña, Mieres, Spain)
| |
D-dimer elevation is associated with severity of community-acquired pneumonia according to CURB-65 and PSI D. Snijders, P. C. Bartels, C. S. de Graaff, W. G. Boersma (Alkmaar, Netherlands)
| |
Can procalcitonin testing reduce antibiotic prescribing for respiratory infections? R. Dhar, K. Desai, G. Bignardi (Sunderland, United Kingdom)
| |
Acute phase proteins (APP) and serum iron in patients (pts) with simple community-acquired pneumonia (CAP) D. B. Nastasijevic, T. Pejcic, T. Radjenovic, M. Radovic (Nish, Serbia And Montenegro)
| |
Correlation of procalcitonin and CRP in community-acquired pneumonia with CRB-65 score and prognosis – results from the German competence network CAPNETZ S. Krueger, K. Richter, S. Pauls, C. Kropf, C. Schumann, V. Hombach, R. Marre (Ulm, Germany)
| |
Diagnostic value of procalcitonin, CRP, leukocytes and BAL neutrophils for pulmonary complications in the immunocompromised host D. Stolz, A. Stulz, B. Mueller, M. Tamm (Basel, Switzerland)
| |